The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 25, 2022
Filed:
Nov. 01, 2021
Applicant:
Somerset Therapeutics, Llc, Hollywood, FL (US);
Inventors:
Mandar V. Shah, Rockaway, NJ (US);
Veerappan Subramanian, Warren, NJ (US);
Ilango Subramanian, Warren, NJ (US);
Ojas Prakashbhai Doshi, Somerville, NJ (US);
Assignee:
Somerset Therapeutics, LLC, Hollywood, FL (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7036 (2006.01); A61K 9/00 (2006.01); A61K 47/34 (2017.01); A61K 47/18 (2017.01); A61K 47/54 (2017.01); A61K 47/60 (2017.01); A61P 27/02 (2006.01); A61P 31/04 (2006.01); A61K 31/573 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7036 (2013.01); A61K 9/0048 (2013.01); A61K 31/573 (2013.01); A61K 45/06 (2013.01); A61K 47/183 (2013.01); A61K 47/34 (2013.01); A61K 47/545 (2017.08); A61K 47/60 (2017.08); A61P 27/02 (2018.01); A61P 31/04 (2018.01);
Abstract
Disclosed herein are compositions comprising tobramycin or a tobramycin derivative that exhibit improvements in permeation of corneal cells, retention in corneal cells, or both. Such compositions can comprise tobramycin or tobramycin derivative(s) complexed to an agent which facilitates improved permeation of corneal cells, retention in corneal cells, or both. The invention also relates to a process of preparing such compositions.